News

The PNC Financial Services Group Q2 Earnings Call Highlights

PNC

Fiserv’s Debit Network Talks Raise a Bigger Question for Visa and MastercardThe PNC Financial Services Group (NYSE:PNC) reported what Chairman and CEO Bill Demchak called an “impressive” second quarter, with management pointing to broad-based business momentum, stronger fee incom

Stocks Supported By Favorable Inflation News

BLK, AMAT, PXED, SNDK, TRI, ELV, MSFT, PNR, STX, LRCX, TRV, SPY, DIA, KLAC, PYPL, HUM, ADSK, CI, MOH, MU, ORCL, CAH, KRMN, MMM, WDAY, QQQ, NOW, ADBE, CNC, TEAM, SOXX, CTAS, CRM, MRVL, LION

The S&P 500 Index ($SPX ) (SPY ) today is up +0.23%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.26%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.31%. September E-mini S&P futures (ESU26 ) are up +0.27%, and September E-mini Nasdaq futures...

Buy SpaceX shares ahead of this week's Starship launch, says UBS

UBS

UBS keeps its buy rating and sees SpaceX reaching huge milestones if its next test flight is successful.

Jim Cramer sees more upside for Goldman and addresses Wells Fargo's biggest question

WFC, WFCN, WFCCL, WFCNP, WFCUS

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

U.S. agency to vote to end 39% local TV station ownership cap

The FCC in March approved the sale of ‌local station owner Tegna to Nexstar, which would expand Nexstar's presence to cover 80% of U.S. ​TV households.

Brewdog co-founder James Watt launches bid to buy back beer firm

Watt says he has made an offer to buy back the craft beer business months after it was sold to a US company.

First Horizon Q2 Earnings Call Highlights

FHN

Banking and trucking: Is the economy rolling toward troubles?First Horizon (NYSE:FHN) reported higher adjusted earnings and continued loan growth in the second quarter of 2026, with management saying the bank remains on track with its full-year expectations despite deposit compet

Elevance Health Q2 Earnings Call Highlights

ELV

This ETF Is Proof That the Healthcare Rebound Is RealElevance Health (NYSE:ELV) raised its 2026 adjusted earnings outlook after second-quarter results came in ahead of management’s expectations, citing favorable benefit expense performance, disciplined cost management and improvi

Biogen Shares Decline After Detailed Diranersen Alzheimer's Study Data

BIIB, LLY, IONS

BIIB's Alzheimer's drug data presentation reaffirms a phase II setback as investors weigh plans to advance diranersen in phase III despite missed goals.

J&J Q2 Earnings Beat on Darzalex, Tremfya Growth, 2026 Outlook Raised

JNJ, AMGN, TEVA, EXEL

JNJ tops Q2 earnings and sales estimates, driven by key drug growth, and raises its 2026 outlook despite a slight MedTech sales miss.